Pioglit Mf Forte
✅ Manages blood sugar levels
✅ Combines two effective drugs
✅ Enhances glycemic control
✅ Reduces insulin resistance
✅ Improves overall diabetes management
Pioglit Mf Forte contains Pioglitazone and Metformin
✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026
⚡ Quick Answer — What is Pioglit MF Forte?
Pioglit MF Forte is a fixed-dose combination tablet of pioglitazone (15 mg) and metformin (850 mg) for type 2 diabetes. It pairs two insulin-sensitising mechanisms: metformin cuts hepatic glucose production, and pioglitazone activates PPAR-γ to reduce peripheral insulin resistance. Expected HbA1c fall: 1.5–2.0 points. No hypoglycaemia when used alone (neither component stimulates insulin release). Typical dose: one tablet twice daily with meals. Main trade-offs: weight gain (2–4 kg), fluid retention and oedema, and the usual metformin GI upset in the first two weeks. Avoid in heart failure, eGFR < 30, active bladder cancer, and severe hepatic impairment.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Pioglit MF Forte?
Pioglit MF Forte is a fixed-dose combination oral antidiabetic tablet containing pioglitazone (15 mg) and metformin hydrochloride (850 mg), manufactured by Sun Pharma. Available in packs of 30, 60, 90 or 180 tablets. It is used in adults with type 2 diabetes when single-agent metformin is not sufficient and insulin resistance is thought to be a major driver of hyperglycaemia.
How Does Pioglit MF Forte Work?
Pioglit MF Forte pairs two complementary mechanisms that both target insulin resistance without stimulating insulin release:
- Metformin — activates AMPK in the liver, cutting hepatic gluconeogenesis by roughly one third. It also improves peripheral insulin sensitivity and modestly slows intestinal glucose absorption.
- Pioglitazone — a PPAR-γ agonist that improves insulin sensitivity in muscle and fat, shifts fat storage from visceral to subcutaneous depots, and improves hepatic steatosis.
Because neither drug stimulates insulin release, the combination does not cause hypoglycaemia on its own. HbA1c reduction is typically 1.5–2.0 percentage points. Pioglitazone also improves HDL and triglycerides and may benefit non-alcoholic fatty liver disease.
Dosage and Administration
Usual dose: one tablet once or twice daily with food. The starting dose is chosen to match the patient’s current therapy; titrate upward every 4–8 weeks based on HbA1c and tolerability. Maximum daily dose: pioglitazone 45 mg + metformin 2,000 mg.
- Take with food — reduces metformin GI upset.
- Allow 8–12 weeks before judging the pioglitazone component — it is slow-onset.
- Renal dosing. Avoid if eGFR < 30. Halve metformin if eGFR 30–45.
- Hold for IV contrast, surgery, or acute illness with dehydration.
- Monitor weight, ankle oedema, ALT, and vitamin B12 periodically.
Side Effects
From metformin (first 1–2 weeks): diarrhoea, nausea, abdominal cramps, metallic taste, flatulence. Usually improve with time or SR formulation.
From pioglitazone:
- Weight gain (2–4 kg)
- Peripheral oedema — most common reason for stopping
- Mild anaemia (haemodilution)
- Headache, myalgia, upper respiratory infection
- Rare: heart failure decompensation, bladder cancer signal (long-term high-dose), macular oedema, bone fracture (women)
Rare but serious (metformin): lactic acidosis — almost always in the setting of AKI, sepsis, or hypoxia. Vitamin B12 deficiency with long-term use; check annually.
Drug Interactions
- Gemfibrozil — doubles pioglitazone levels; limit pioglitazone to 15 mg/day.
- Rifampicin — reduces pioglitazone levels.
- IV iodinated contrast — hold metformin (48 hours post-procedure if eGFR < 60).
- Insulin — additive fluid retention; be alert for oedema and heart failure.
- Sulfonylureas / meglitinides / insulin — add hypoglycaemia risk (absent on Pioglit MF Forte alone).
- Cationic drugs (cimetidine, dolutegravir, ranolazine) — raise metformin levels.
Who Should Not Take Pioglit MF Forte?
- Heart failure (NYHA III–IV)
- Active bladder cancer or previous bladder cancer
- Unexplained macroscopic haematuria
- Severe renal impairment (eGFR < 30)
- Severe hepatic impairment or ALT > 2.5× upper limit of normal
- Diabetic ketoacidosis; type 1 diabetes
- Acute illness with risk of tissue hypoxia
- Pregnancy, breastfeeding
- Known hypersensitivity to either component
Storage
Store Pioglit MF Forte below 30°C in a dry place. Keep out of reach of children.
Frequently Asked Questions
Is Pioglit MF Forte the same as taking metformin and pioglitazone separately?
Clinically, yes — same molecules, same doses. The fixed-dose combination simplifies the regimen (one tablet instead of two), typically improves adherence, and is usually less expensive than the two components bought separately.
Will Pioglit MF Forte cause hypoglycaemia?
Not on its own — neither metformin nor pioglitazone stimulates insulin release. Hypoglycaemia only becomes a concern when Pioglit MF Forte is combined with a sulfonylurea, meglitinide, or insulin.
Does Pioglit MF Forte cause weight gain?
Pioglitazone causes 2–4 kg weight gain, partly offset by metformin’s weight-neutral or slightly weight-reducing effect. Net change is usually 1–3 kg gained over the first year.
Can I take Pioglit MF Forte if I have fatty liver or NASH?
Yes — pioglitazone is one of the few drugs with good evidence in non-alcoholic steatohepatitis (PIVENS trial showed histological improvement). Metformin has more limited NASH-specific evidence but is weight-favourable and reduces hepatic glucose output.
What if I have mild fluid retention?
Mild ankle swelling can sometimes be managed with dose reduction or adding a diuretic. Breathlessness, rapid weight gain, or new peripheral oedema warrants prompt medical review — pioglitazone may need stopping.
Can I drink alcohol while taking Pioglit MF Forte?
Moderate alcohol with food is usually safe. Avoid binge drinking — it raises lactic acidosis risk (metformin) and can impair liver function (both drugs).
Where can I buy Pioglit MF Forte online?
You can order Pioglit MF Forte (Pioglitazone 15 mg + Metformin 850 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.
Related Diabetes Medications
- Pioz 15 — Pioglitazone 15 mg monotherapy
- Glycomet SR — Metformin sustained-release
- Januvia — Sitagliptin (DPP-4 inhibitor)
- Jardiance — Empagliflozin (SGLT-2 inhibitor)
- Glisen PM — Glimepiride + Pioglitazone + Metformin triple combo
- Browse all Diabetes Medications
More options in Diabetes
Ranked by recent MedsBase order volume — what other customers in this category are picking.
| Strength | 15 mg + 850 mg |
|---|---|
| Quantity | 30 Tablet/s, 60 Tablet/s, 90 Tablet/s |
| Pharma Form | Tablet/s |
| Manufacturer | Sun Pharma |
| Treatment | Type 2 diabetes |
Pioglit Mf Forte
Ερωτήσεις & Απαντήσεις
Pioglit Mf Forte
Σχετικά προϊόντα
Κριτικές
Δεν υπάρχουν ακόμη κριτικές